Published on
February 3, 2022
- 13:00 GMT
Sedia Biosciences Announces ISO 13485 Certification for Production of HIV In Vitro Diagnostics Tests
Beaverton Oregon Facilities Certified with International Quality Standard BEAVERTON, OREGON, UNITED STATES, February 3, 2022 /EINPresswire.com/ -- Sedia Biosciences Corporation today announced that it has received ISO 13485:2016 Certification of its Beaverton, OR facilities for the production and distribution of two of its key Products. ISO 13485 is an internationally recognized quality standard for medical devices and Certification was provided by TÜV SÜD Product Service GmbH, of Munich Germany, an …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...